Institutional investors purchased a net $13.7 thousand shares of BIOC during the quarter ended June 2016. This may signal that the smart money is gaining interest in this company as the 4.18% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ADVISORY SERVICES NETWORK LLC Bought 334.00 shares of Biocept Inc
METLIFE SECURITIES, INC. Sold 1.00 shares of Biocept Inc
CREATIVE PLANNING, INC. Sold 52.2 Thousand shares of Biocept Inc